[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351493-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351493-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","machine-learning-based-pathomics-signature-in-predicting-msh2-expression-and-prognosis-in-gastric-cancer","Machine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer","","Machine learning-derived digital pathomics features were used to predict MSH2 expression and clinical outcomes in gastric cancer. Hematoxylin and eosin whole-slide images from 234 patients supported extraction of quantitative pathological features and construction of a pathomics score (PS). PS association with overall survival was evaluated using univariate and multivariate Cox regression, with Kaplan-Meier analyses for high- versus low-PS groups. Functional enrichment and immune infiltration analyses explored potential mechanisms, showing PS stratified prognostic subgroups and reflected immune-related microenvironment differences.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/machine-learning-based-pathomics-signature-in-predicting-msh2-expression-and-prognosis-in-gastric-cancer/351493/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/machine-learning-based-pathomics-signature-in-predicting-msh2-expression-and-prognosis-in-gastric-cancer/351493.png","ImageObject",300,407,{"name":42,"@type":43},"Sarah ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of the study regarding MSH2 in gastric cancer?","Question",{"text":63,"@type":64},"To determine whether machine learning-derived digital pathomics features could predict MSH2 expression and clinical outcomes in gastric cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the pathomics score (PS) constructed and evaluated?",{"text":68,"@type":64},"Quantitative features were extracted from H&E-stained whole-slide images of 234 patients, and a PS was developed to estimate MSH2 expression. Its association with overall survival was tested using univariate and multivariate Cox regression and Kaplan-Meier comparisons.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about high-PS versus low-PS patients?",{"text":72,"@type":64},"Digital image analysis linked pathomics features to MSH2 expression. High PS was associated with stronger antitumor immune response features and distinct prognostic outcomes compared with low PS, which aligned with an immunosuppressive microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351493,1790636427,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","ARTICLE 1  \n\n| INTRODUCTION: Gastric cancer (GC) is one of the most prevalent and lethal gastrointestinal malignancies. MutS homolog 2 (MSH2), a DNA mismatch repair protein, has emerged as a promising prognostic biomarker. However, traditional histopathological evaluation is limited by restricted fields compared with wholeslide imaging. This study aimed to investigate whether machine learning-derived digital pathomics features could predict MSH2 expression and clinical outcomes in GC.\u003Cbr>METHODS: Hematoxylin and eosin-stained whole-slide images from 234 patients were analyzed to extract quantitative pathological features. A pathomics score (PS) was developed to estimate MSH2 expression. The association between PS and overall survival (OS) was assessed using univariate and multivariate Cox regression. Survival differences between high-PS and low-PS groups were evaluated using Kaplan-Meier analysis. Functional enrichment and immune infiltration analyses were performed to explore potential biological mechanisms.\u003Cbr>RESULTS: Digital image analysis identified pathomics features associated with MSH2 expression. The PS served as a surrogate marker for MSH2 and effectively stratified patients into prognostic subgroups with significant different OS. High PS was associated with features suggestive of a stronger antitumor immune response, whereas low PS was linked to an immunosuppressive microenvironment.\u003Cbr>DISCUSSION: The machine learning-derived pathomics signature shows potential in predicting MSH2 expression. It can serve as a complementary research tool and provide clinically meaningful prognostic information for GC.\u003Cbr>KEYWORDS: gastric cancer; machine learning algorithm; MSH2; pathomics signature; prognosis\u003Cbr>ABBREVIATIONS: AUC, area under the curve; GAC, gastric adenocarcinoma; GBM, gradient boosting machine; GC, gastric cancer; GO, Gene Ontology; H&E, hematoxylin and eosin; KEGG, Kyoto Encyclopedia of Genes and Genomes; MMR, mismatch repair; mRMR, maximal relevance minimum redundancy; MSH2, MutS homolog 2; MSI, microsatellite instability; OS, overall survival; PS, pathomics score; RFE, recursive feature elimination; ROC, receiver operating characteristic; STAD, stomach adenocarcinoma; TCGA, The Cancer Genome Atlas; TNM, tumor node metastasis; WSI, whole-slide imaging |  |\n| --- | --- |\n| Clinical and Translational Gastroenterology 2026;17:e00985. [https://doi.org/10.14309/ctg.0000000000000985](https://doi.org/10.14309/ctg.0000000000000985) |  |\n| INTRODUCTION\u003Cbr>Gastric cancer (GC) remains one of the most common and fatal malignancies of the gastrointestinal system (1) . Gastric adenocarcinoma (GAC), which accounts for more than 95% of GC cases, continues to represent a major global health burden (1,2) . Early-stage GAC (stage I) can be treated using endoscopic | submucosal dissection or radical resection, whereas advanced GAC (stages II–III) typically requires multimodal therapy combining surgery with adjuvant treatment (3). However, traditional prognostic indicators are no longer suﬃcient in the era of precision medicine. Risk assessment based solely on the tumor node metastasis (TNM) staging system is often inadequate for guiding |\n\nMachine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer  \nZheng-Rong Zhang, MM1 ,2 , Yu Wang, MM2 , Wen-Wu Yan, MM2 , Hao-Ran Li, MM2 , Zheng-Wu Cheng, MM2 , Ting Han, MM2 , Chao Zhang, MD1 and Xiao-Ming Wang, MD1 ,2  \nSTOMACH  \n1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 2Department of Gastrointestinal Surgery, The First Affiliated Hospital ofWannan Medical College (Yijishan Hospital ofWannan Medical College), Wuhu, China. Correspondence: Xiao-Ming Wang, MD. E-mail: wxiaomingwxm@126 .com Chao Zhang, MD. E-mail: [zhangchao_amu1@126.com](zhangchao_amu1@126.com).  \nReceived September 24, 2025; accepted January 22, 2026; published online February 6, 2026  \n© 2026 The Au","cbCaiiPFnrPNjtiz","https://ap.wps.com/l/cbCaiiPFnrPNjtiz","pdf",2346608,16,"English","# Introduction\n# Methods\n# Results\n# Discussion\n# Keywords\n# Abbreviations","[{\"question\":\"What was the goal of the study regarding MSH2 in gastric cancer?\",\"answer\":\"To determine whether machine learning-derived digital pathomics features could predict MSH2 expression and clinical outcomes in gastric cancer.\"},{\"question\":\"How was the pathomics score (PS) constructed and evaluated?\",\"answer\":\"Quantitative features were extracted from H\\u0026E-stained whole-slide images of 234 patients, and a PS was developed to estimate MSH2 expression. Its association with overall survival was tested using univariate and multivariate Cox regression and Kaplan-Meier comparisons.\"},{\"question\":\"What did the results show about high-PS versus low-PS patients?\",\"answer\":\"Digital image analysis linked pathomics features to MSH2 expression. High PS was associated with stronger antitumor immune response features and distinct prognostic outcomes compared with low PS, which aligned with an immunosuppressive microenvironment.\"}]","Machine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer | PDF",1790094410,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b70fcaf35561675f4925b272b689061.webp",983,1296,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b715ceb7a144d027713a33b6ddd2f357.webp",982,1294,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21a18b1aeb16807a4c9f59a2f64ab3bb.webp",981,1293,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93f8191b22c2f9f2076826af33512480.webp",980,1292]